INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 145 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $18,000 | -14.3% | 950 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $21,000 | -8.7% | 950 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $23,000 | -100.0% | 950 | -99.9% | 0.00% | -100.0% |
| Q3 2020 | $49,793,000 | -13.5% | 1,201,000 | 0.0% | 5.86% | -8.4% |
| Q2 2020 | $57,539,000 | -20.9% | 1,201,000 | +4.0% | 6.40% | -31.0% |
| Q1 2020 | $72,718,000 | -31.8% | 1,155,000 | +34.3% | 9.28% | +4.9% |
| Q4 2019 | $106,571,000 | +88.7% | 860,000 | +1.1% | 8.85% | +25.0% |
| Q3 2019 | $56,472,000 | -6.2% | 851,000 | +12.4% | 7.08% | -5.8% |
| Q2 2019 | $60,234,000 | +68.3% | 757,000 | +136.6% | 7.51% | +39.3% |
| Q1 2019 | $35,795,000 | +557.8% | 320,000 | +492.6% | 5.39% | +346.8% |
| Q4 2018 | $5,442,000 | -83.3% | 54,000 | -79.0% | 1.21% | -83.2% |
| Q3 2018 | $32,537,000 | -39.0% | 257,500 | -59.5% | 7.18% | -32.8% |
| Q2 2018 | $53,308,000 | +36.4% | 635,300 | 0.0% | 10.69% | +18.2% |
| Q1 2018 | $39,083,000 | +267.0% | 635,300 | +248.5% | 9.04% | +231.8% |
| Q4 2017 | $10,649,000 | – | 182,300 | – | 2.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |